Both in Pharmaceuticals
Summit Therapeutics vs BridgeBio Pharma
Over the past year SMMT returned −22.5% and BBIO returned +27.0%; their daily moves had a correlation of 0.32.
SMMT −22.5% BBIO +27.0%Growth of $1, one year, split-adjusted
| Metric | SMMT | BBIO |
|---|---|---|
| Price | $16.39 | $65.97 |
| Market cap | $13.08B | $12.90B |
| Today | +5.88% | −0.96% |
| 1 month | +19.4% | −13.9% |
| 6 months | −3.5% | −4.9% |
| Year to date | −6.3% | −13.8% |
| 1 year | −21.8% | +31.8% |
| Revenue growth (YoY) | — | +120.4% |
| Gross margin | — | 93.8% |
| Net margin | — | −62.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 18.1× |
| Net cash | $690.7M | -$1.76B |
| Dividend yield | — | — |
| Volatility (60d) | 69.5% | 42.8% |
| Short % of float | 29.9% | 13.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).